ReviewBMC medicine2014
Update on the NCEP ATP-III emerging cardiometabolic risk factors.
Review in BMC medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 2 syntheses or guidelines pooled it, 88 citations in OpenAlex.
- Effects of resistant starch consumption on anthropometric and serum parameters in adults with metabolic syndrome-related risks: a systematic review and meta-analysis.Frontiers in nutrition · 2025Pooled it
- Muscular Fitness and Cardiometabolic Variables in Children and Adolescents: A Systematic Review.Sports medicine (Auckland, N.Z.) · 2022Pooled it
- A Prospective Study on Clinical Profile and the Utility of 72-h Holter Monitoring in Acute Ischaemic Stroke and Transient Ischaemic Attack (TIA) Patients.Annals of neurosciences · 2026Article
- Low BMI predicts mortality in T2DM older adults: cholesterol parameters demonstrate negative mediation.Diabetology & metabolic syndrome · 2026Article
- Dietary protein intake in relation to metabolic syndrome reversion: findings from the Tehran lipid and glucose study.Scientific reports · 2026Article
- Relationship between skipping breakfast and metabolic syndrome among adults aged 35-74 years: a cross-sectional study in Northwest China, 2018-2020.Frontiers in nutrition · 2026Article
- Low-grade inflammation score (INFLA- score) associated with metabolic syndrome and its components in shift workers.Diabetology & metabolic syndrome · 2025Article
- Association Between Dyslipidemia and Lichen Planus: A Cross-Sectional Study in a Tertiary Care Hospital.Cureus · 2025Article
- Comparative Effectiveness of Wearable Devices and Built-In Step Counters in Reducing Metabolic Syndrome Risk in South Korea: Population-Based Cohort Study.JMIR mHealth and uHealth · 2025Article
- The Association Between Beverages Consumption Patterns, Metabolic Risk Factors, and Anthropometric Features Among Overweight and Obese Adults: A Cross-Sectional Study.Nutrition and metabolic insights · 2025Article
- Compare and Contrast of the Cellular Actions of Related Flavonoids, Apigenin and Chrysin.Nutrients · 2024Review
- Assessments of coagulation profile among good glycemic control and poor glycemic control type 2 diabetic patient attending at Wolkite University specialized hospital, Central Ethiopia: a comparative study.BMC endocrine disorders · 2024Article
- Cardiovascular Risk Factors in Socioeconomically Disadvantaged Populations in a Suburb of the Largest City in Western Romania.Biomedicines · 2024Article
- A comparative evaluation of the efficacy of complete decongestive therapy in the treatment of unilateral breast cancer-related lymphedema with and without metabolic syndrome.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024Article
- Obesity and the kidney: mechanistic links and therapeutic advances.Nature reviews. Endocrinology · 2024Review
- Weight and Lipid Levels in People Living With HIV and Initiating a Dolutegravir-Based Regimen in a Resource Limited Setting: A Prospective Study.AIDS research and treatment · 2024Article
- Modulation of cardiometabolic risk and CardioRenal syndrome by oral vitamin DRenal failure · 2022Article
- Effect of lifestyle modification for two years on obesity and metabolic syndrome components in elementary students: A community- based trial.Caspian journal of internal medicine · 2022Article
- Association between physical activity and serum liver aminotransferases in Southwestern Iran: A Cross-sectional study.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2022Article
- Betatrophin Levels Are Related to the Early Histological Findings in Nonalcoholic Fatty Liver Disease.Metabolites · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
The intent of this review is to update the science of emerging cardiometabolic risk factors that were listed in the National Cholesterol Education Program (NCEP) Adult Treatment Panel-III (ATP-III) report of 2001 (updated in 2004). At the time these guidelines were published, the evidence was felt to be insufficient to recommend these risk factors for routine screening of cardiovascular disease risk. However, the panel felt that prudent use of these biomarkers for patients at intermediate risk of a major cardiovascular event over the subsequent 10 years might help identify patients who needed more aggressive low density lipoprotein (LDL) or non-high density lipoprotein (HDL) cholesterol lowering therapy. While a number of other emerging risk factors have been identified, this review will be limited to assessing the data and recommendations for the use of apolipoprotein B, lipoprotein (a), homocysteine, pro-thrombotic factors, inflammatory factors, impaired glucose metabolism, and measures of subclinical atherosclerotic cardiovascular disease for further cardiovascular disease risk stratification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.